CFO Buys $129K in Cardlytics Stock Near 52-Week Lows
CDLX is trading near its 52-week low of $0.57 (4.6% above the low).
Summary
Cardlytics' CFO purchased $129,000 of company stock on the open market, signaling executive confidence as the stock trades near its 52-week low.
Key Events · Ownership and Investor Activity · CDLX
-
CFO Open Market Purchase
David Thomas Evans, the Chief Financial Officer, acquired 200,000 shares for a total of $129,000 through open market transactions between May 15 and May 18, 2026.
-
Executive Confidence at Lows
This purchase occurred while the stock is trading near its 52-week low of $0.57, indicating strong conviction from a key executive.
-
Counter to Recent Insider Trend
The CFO's buy contrasts with a net insider distribution of approximately $330,000 over the last 90 days, potentially signaling a shift in insider sentiment.
-
Post-Transaction Holdings
Following these transactions, the CFO directly holds 317,930 shares of Cardlytics common stock.
Analysis · CDLX · Technology
Cardlytics' CFO, David Thomas Evans, made a significant open-market purchase of $129,000 worth of company stock. This purchase, occurring while the stock trades near its 52-week low, represents a strong vote of confidence from a key executive, especially given recent insider distribution and the company's ongoing efforts to improve profitability despite revenue declines.
At the time of this filing, CDLX was trading at $0.60 on NASDAQ in the Technology sector, with a market capitalization of approximately $34.3M. The 52-week trading range was $0.57 to $3.28. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.